Literature DB >> 18229794

Low-cholesterol diet and antilipid therapy in managing tinnitus and hearing loss in patients with noise-induced hearing loss and hyperlipidemia.

Aziz Sutbas1, Sertac Yetiser, Bulent Satar, Timur Akcam, Serdar Karahatay, Kenan Saglam.   

Abstract

The aim of our study was to outline the prevalence of hyperlipidemia in patients who had high-frequency hearing loss and tinnitus due to noise exposure. We investigated the role of a low-cholesterol diet and antihyperlipidemic therapy to alleviate the severity of tinnitus and possibly promote hearing gain after therapy in patients with acoustic trauma. Forty-two hyperlipidemic patients with subjective tinnitus and hearing loss due to noise exposure were enrolled for the study. We placed patients on a low-cholesterol diet or antihyperlipidemic therapy and followed them for up to 24 months; then we designated two groups as either "unresponsive" (n = 22; no response to either of the therapies and still experiencing hyperlipidemia) or "responsive" (n = 20; lower cholesterol or triglyceride levels). We then compared tinnitus scores and hearing levels in the two groups. The difference between tinnitus scores in the unresponsive and responsive groups and the change in tinnitus scores before and after therapy in the responsive group were significant. When we compared self-rated tinnitus severity results in two groups after therapy, we found the difference was significant (p < .05). The difference between average air-conduction thresholds at high frequencies after the treatment in the two groups was also significant. The incidence of hyperlipidemia is high among patients with noise-induced hearing loss, and significant improvement by way of lowered tinnitus intensity and higher frequencies in average hearing thresholds can be achieved after lowering the serum lipid level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18229794

Source DB:  PubMed          Journal:  Int Tinnitus J        ISSN: 0946-5448


  10 in total

1.  Lipid Profile among Patients with Sudden Sensorineural Hearing Loss.

Authors:  Ali A Muttalib Mohammed
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-07-06

2.  Atorvastatin is associated with reduced cisplatin-induced hearing loss.

Authors:  Katharine A Fernandez; Paul Allen; Maura Campbell; Brandi Page; Thomas Townes; Chuan-Ming Li; Hui Cheng; Jaylon Garrett; Marcia Mulquin; Anna Clements; Deborah Mulford; Candice Ortiz; Carmen Brewer; Judy R Dubno; Shawn Newlands; Nicole C Schmitt; Lisa L Cunningham
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

3.  Assessment of auditory function and lipid levels in patients receiving oral isotretinoin (13-cis retinoid) therapy for acne vulgaris.

Authors:  Mahizer Yaldiz; Ahmet Kara; Mehmet Güven; Berna Solak; Rabia Kara; Mustafa Teoman Erdem
Journal:  Postepy Dermatol Alergol       Date:  2018-11-14       Impact factor: 1.837

4.  Effects of Hyperlipidemia on Noise Induced Hearing Loss (NIHL).

Authors:  Afsaneh Doosti; Yones Lotfi; Enayatollah Bakhshi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-05-05

5.  Prevalence of dyslipidemia among Iranian patients with idiopathic tinnitus.

Authors:  Minoo M-Shirazi; Mohammad Farhadi; Maryam Jalessi; Seyyed-Kamran Kamrava; Ashkan Heshmatzade Behzadi; Behin Arami
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

6.  Increased risk of depression in patients with acquired sensory hearing loss: A 12-year follow-up study.

Authors:  Wei-Ting Hsu; Chih-Chao Hsu; Ming-Hsun Wen; Hong-Ching Lin; Hsun-Tien Tsai; Peijen Su; Chi-Te Sun; Cheng-Li Lin; Chung-Yi Hsu; Kuang-Hsi Chang; Yi-Chao Hsu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Associations of Earphone Use with Tinnitus and Anxiety/Depression.

Authors:  Jay Hyug Choi; Sung Su Park; So Young Kim
Journal:  Noise Health       Date:  2021 Oct-Dec       Impact factor: 0.867

8.  Identification of dyslipidemia as a risk factor for sudden sensorineural hearing loss: A multicenter case-control study.

Authors:  Xiaoqing Li; Binghua Chen; Xingxing Zhou; Fan Ye; Yumin Wang; Wangqiang Hu
Journal:  J Clin Lab Anal       Date:  2021-10-21       Impact factor: 2.352

9.  Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.

Authors:  Xindi Zhang; Matthew R Trendowski; Emma Wilkinson; Mohammad Shahbazi; Paul C Dinh; Megan M Shuey; Darren R Feldman; Robert J Hamilton; David J Vaughn; Chunkit Fung; Christian Kollmannsberger; Robert Huddart; Neil E Martin; Victoria A Sanchez; Robert D Frisina; Lawrence H Einhorn; Nancy J Cox; Lois B Travis; M Eileen Dolan
Journal:  Cancer Med       Date:  2022-03-23       Impact factor: 4.711

Review 10.  Tinnitus and sound intolerance: evidence and experience of a Brazilian group.

Authors:  Ektor Tsuneo Onishi; Cláudia Couto de Barros Coelho; Jeanne Oiticica; Ricardo Rodrigues Figueiredo; Rita de Cassia Cassou Guimarães; Tanit Ganz Sanchez; Adriana Lima Gürtler; Alessandra Ramos Venosa; André Luiz Lopes Sampaio; Andreia Aparecida Azevedo; Anna Paula Batista de Ávila Pires; Bruno Borges de Carvalho Barros; Carlos Augusto Costa Pires de Oliveira; Clarice Saba; Fernando Kaoru Yonamine; Ítalo Roberto Torres de Medeiros; Letícia Petersen Schmidt Rosito; Marcelo José Abras Rates; Márcia Akemi Kii; Mariana Lopes Fávero; Mônica Alcantara de Oliveira Santos; Osmar Clayton Person; Patrícia Ciminelli; Renata de Almeida Marcondes; Ronaldo Kennedy de Paula Moreira; Sandro de Menezes Santos Torres
Journal:  Braz J Otorhinolaryngol       Date:  2017-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.